PC3 prostate cancer cells which overexpressed the SOST gene showed less osteolysis when injected into the femur of non-obese diabetic (NOD) scid gamma (NSG) mice and significantly less metastases when administered intravenously [92]. The gene discussed is SOST; the disease is prostate carcinoma.